Technology · Biotechnology R&D expenditure
In 2026, Russia's expenditure on biotechnology research and development was 500 M $, ranking 17 out of 197 countries. Funding for biopharmaceuticals and industrial biotechnology primarily comes through state programs and state-owned corporations like Rosatom and Rostec, while the private sector remains weakly engaged, with investment volumes far behind industry leaders.
Data for 2026 · unit: $
Position
#17 / 197
Russia world ranking
Country position on the scale from last to first place for this indicator.
RU
#17
#197#1
Trend
Change over time
Change in indicator over the available period.
500 M
1990
200 M
2000
300 M
2010
150 M
2020
450 M
2025
500 M
2026
Values — $
Comparison
Top countries by Biotechnology R&D expenditure
Where Russia stands in the world ranking.
1
CNChina
30 B
1
USUSA
30 B
3
JPJapan
25 B
4
MXMexico
1 B
4
BRBrazil
1 B
6
CACanada
800 M
6
DEGermany
800 M
8
ESSpain
650 M
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Biotechnology R&D expenditure in Russia — how much?
Based on 2026 data — 500 M $. This is rank #17 out of 197 countries.
What is Russia's rank by Biotechnology R&D expenditure?
Russia ranks #17 out of 197 countries in the world ranking by «Biotechnology R&D expenditure».
How has Biotechnology R&D expenditure changed in Russia?
Over the available period the indicator changed from 500 M to 500 M $.